L'Hospitalet de Llobregat   Report issue

Academic/Hospital Phase 3
Founded: Barcelona Spain

Organization Overview

First Clinical Trial
2011
NCT01836328
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

L'Hospitalet de Llobregat | Maite Antonio, MD, Phd

Active Ingredients

Drugs in Phase 3 Trials (4)

fentanyl (Innovar) (1 trial)

methadone (methadose) (1 trial)

morphine (1 trial)

tanezumab (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cancer Pain (Phase 3)

Musculoskeletal Pain (Phase 3)

Neoplasm Metastasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4